Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis.

Baker JF, England BR, Mikuls TR, Sayles H, Cannon GW, Sauer BC, George MD, Caplan L, Michaud K.

Arthritis Care Res (Hoboken). 2018 Apr 29. doi: 10.1002/acr.23579. [Epub ahead of print]

PMID:
29707921
2.

Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis Is Associated With Changes in Blood Pressure.

Baker JF, Sauer B, Teng CC, George M, Cannon GW, Ibrahim S, Cannella A, England BR, Michaud K, Caplan L, Davis LA, OʼDell J, Mikuls TR.

J Clin Rheumatol. 2018 Jun;24(4):203-209. doi: 10.1097/RHU.0000000000000736.

PMID:
29664818
3.

Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis.

Wood PR, Manning E, Baker JF, England B, Davis L, Cannon GW, Mikuls TR, Caplan L.

World J Diabetes. 2018 Feb 15;9(2):53-58. doi: 10.4239/wjd.v9.i2.53.

4.

Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance.

Walsh JA, Pei S, Burningham Z, Penmetsa G, Cannon GW, Clegg DO, Sauer BC.

J Rheumatol. 2018 Mar;45(3):430-436. doi: 10.3899/jrheum.170554. Epub 2017 Nov 15.

PMID:
29142040
5.

A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.

Williams ST, Lawrence PT, Miller KL, Crook JL, LaFleur J, Cannon GW, Nelson RE.

Osteoporos Int. 2017 Nov;28(11):3107-3111. doi: 10.1007/s00198-017-4172-3. Epub 2017 Jul 30.

PMID:
28756457
6.

Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity.

Sauer BC, Teng CC, Accortt NA, Burningham Z, Collier D, Trivedi M, Cannon GW.

Arthritis Res Ther. 2017 May 8;19(1):86. doi: 10.1186/s13075-017-1294-0.

7.

Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis.

England BR, Baker JF, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer BC, Solow EB, Reimold AM, Kerr GS, Mikuls TR.

Arthritis Care Res (Hoboken). 2018 Jan;70(1):11-18. doi: 10.1002/acr.23258. Epub 2017 Dec 6.

PMID:
28426913
8.

Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.

George MD, Giles JT, Katz PP, England BR, Mikuls TR, Michaud K, Ogdie-Beatty AR, Ibrahim S, Cannon GW, Caplan L, Sauer BC, Baker JF.

Arthritis Care Res (Hoboken). 2017 Dec;69(12):1789-1798. doi: 10.1002/acr.23229. Epub 2017 Nov 6.

PMID:
28393498
9.

The Bone Health Team: A Team-Based Approach to Improving Osteoporosis Care for Primary Care Patients.

Lawrence PT, Grotzke MP, Rosenblum Y, Nelson RE, LaFleur J, Miller KL, Ma J, Cannon GW.

J Prim Care Community Health. 2017 Jul;8(3):135-140. doi: 10.1177/2150131916687888. Epub 2017 Jan 17.

10.

Validity evidence for two objective structured clinical examination stations to evaluate core skills of the shoulder and knee assessment.

Battistone MJ, Barker AM, Beck JP, Tashjian RZ, Cannon GW.

BMC Med Educ. 2017 Jan 13;17(1):13. doi: 10.1186/s12909-016-0850-7.

11.

Does Psychological Safety Impact the Clinical Learning Environment for Resident Physicians? Results From the VA's Learners' Perceptions Survey.

Torralba KD, Loo LK, Byrne JM, Baz S, Cannon GW, Keitz SA, Wicker AB, Henley SS, Kashner TM.

J Grad Med Educ. 2016 Dec;8(5):699-707. doi: 10.4300/JGME-D-15-00719.1.

12.

"Mini-Residency" in Musculoskeletal Care: a National Continuing Professional Development Program for Primary Care Providers.

Battistone MJ, Barker AM, Grotzke MP, Beck JP, Lawrence P, Cannon GW.

J Gen Intern Med. 2016 Nov;31(11):1301-1307. doi: 10.1007/s11606-016-3773-4. Epub 2016 Jun 27.

13.

Utilization of Care Outside the Veterans Affairs Health Care System by US Veterans With Rheumatoid Arthritis.

Schwab P, Sayles H, Bergman D, Cannon GW, Michaud K, Mikuls TR, Barton J.

Arthritis Care Res (Hoboken). 2017 Jun;69(6):776-782. doi: 10.1002/acr.23088. Epub 2017 May 9.

14.

The use of natural language processing on narrative medication schedules to compute average weekly dose.

Lu CC, Leng J, Cannon GW, Zhou X, Egger M, South B, Burningham Z, Zeng Q, Sauer BC.

Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1414-1424. doi: 10.1002/pds.4086. Epub 2016 Sep 16.

PMID:
27633139
15.

Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans.

Sokolove J, Wagner CA, Lahey LJ, Sayles H, Duryee MJ, Reimold AM, Kerr G, Robinson WH, Cannon GW, Thiele GM, Mikuls TR.

Rheumatology (Oxford). 2016 Nov;55(11):1969-1977. Epub 2016 Jul 31.

16.

Effectiveness of an Interprofessional and Multidisciplinary Musculoskeletal Training Program.

Battistone MJ, Barker AM, Grotzke MP, Beck JP, Berdan JT, Butler JM, Milne CK, Huhtala T, Cannon GW.

J Grad Med Educ. 2016 Jul;8(3):398-404. doi: 10.4300/JGME-D-15-00391.1.

17.

Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis.

Cannon GW, DuVall SL, Haroldsen CL, Caplan L, Curtis JR, Michaud K, Mikuls TR, Reimold A, Collier DH, Joseph GJ, Harrison DJ, Sauer BC.

Adv Ther. 2016 Aug;33(8):1347-59. doi: 10.1007/s12325-016-0371-0. Epub 2016 Jun 28.

18.

Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.

Sauer BC, Teng CC, Tang D, Leng J, Curtis JR, Mikuls TR, Harrison DJ, Cannon GW.

Arthritis Care Res (Hoboken). 2017 Mar;69(3):313-322. doi: 10.1002/acr.22944.

19.

Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis.

England BR, Sokolove J, Robinson WH, Thiele GM, Ganti AK, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer B, Singh N, Blair Solow E, Reimold AM, Kerr GS, Schwab P, Baker JF, Mikuls TR.

Arthritis Rheumatol. 2016 Oct;68(10):2394-402. doi: 10.1002/art.39735.

20.

Has Interprofessional Education Changed Learning Preferences? A National Perspective.

Kashner TM, Hettler DL, Zeiss RA, Aron DC, Bernett DS, Brannen JL, Byrne JM, Cannon GW, Chang BK, Dougherty MB, Gilman SC, Holland GJ, Kaminetzky CP, Wicker AB, Keitz SA.

Health Serv Res. 2017 Feb;52(1):268-290. doi: 10.1111/1475-6773.12485. Epub 2016 Mar 18.

21.

Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis.

Baker JF, Sauer BC, Cannon GW, Teng CC, Michaud K, Ibrahim S, Jorgenson E, Davis L, Caplan L, Cannella A, Mikuls TR.

Arthritis Rheumatol. 2016 Aug;68(8):1818-27. doi: 10.1002/art.39647.

22.

Reply.

Baker JF, Ibrahim S, Billig E, Michaud K, Caplan L, Cannon GW, Stokes A, Majithia V, Mikuls TR.

Arthritis Rheumatol. 2016 Feb;68(2):553-4. doi: 10.1002/art.39495. No abstract available.

23.

Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis.

Sauer BC, Teng CC, He T, Leng J, Lu CC, Walsh JA, Shah N, Harrison DJ, Tang DH, Cannon GW.

J Med Econ. 2016;19(1):34-43. doi: 10.3111/13696998.2015.1086774. Epub 2015 Sep 30.

PMID:
26337538
24.

Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.

England BR, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer BC, Solow EB, Reimold AM, Kerr GS, Schwab P, Baker JF, Mikuls TR.

Arthritis Care Res (Hoboken). 2016 Jan;68(1):36-45. doi: 10.1002/acr.22642.

25.

Mini-Residency in Musculoskeletal Care: An Interprofessional, Mixed-Methods Educational Initiative for Primary Care Providers.

Battistone MJ, Barker AM, Lawrence P, Grotzke MP, Cannon GW.

Arthritis Care Res (Hoboken). 2016 Feb;68(2):275-9. doi: 10.1002/acr.22644.

26.

Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis.

Baker JF, Billig E, Michaud K, Ibrahim S, Caplan L, Cannon GW, Stokes A, Majithia V, Mikuls TR.

Arthritis Rheumatol. 2015 Jul;67(7):1711-7. doi: 10.1002/art.39136.

27.

Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors and mortality.

Solow EB, Yu F, Thiele GM, Sokolove J, Robinson WH, Pruhs ZM, Michaud KD, Erickson AR, Sayles H, Kerr GS, Gaffo AL, Caplan L, Davis LA, Cannon GW, Reimold AM, Baker J, Schwab P, Anderson DR, Mikuls TR.

Rheumatology (Oxford). 2015 Sep;54(9):1587-95. doi: 10.1093/rheumatology/kev027. Epub 2015 Apr 7.

28.

Predictors of longterm changes in body mass index in rheumatoid arthritis.

Baker JF, Cannon GW, Ibrahim S, Haroldsen C, Caplan L, Mikuls TR.

J Rheumatol. 2015 Jun;42(6):920-7. doi: 10.3899/jrheum.141363. Epub 2015 Apr 1.

29.

Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2).

Gibofsky A, Cannon GW, Harrison DJ, Joseph GJ, Bitman B, Chaudhari S, Collier DH.

Clin Exp Rheumatol. 2015 May-Jun;33(3):297-301. Epub 2015 Feb 18.

PMID:
25738333
30.

Mortality in American Veterans with the HLA-B27 gene.

Walsh JA, Zhou X, Clegg DO, Teng C, Cannon GW, Sauer B.

J Rheumatol. 2015 Apr;42(4):638-44. doi: 10.3899/jrheum.140675. Epub 2015 Feb 15.

PMID:
25684766
31.

Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration.

Navarro-Millán I, Yang S, DuVall SL, Chen L, Baddley J, Cannon GW, Delzell ES, Zhang J, Safford MM, Patkar NM, Mikuls TR, Singh JA, Curtis JR.

Ann Rheum Dis. 2016 Feb;75(2):341-7. doi: 10.1136/annrheumdis-2013-204987. Epub 2015 Jan 21.

32.

Spinal epidural abscess following minimally invasive dental examination in a rheumatoid arthritis patient receiving methotrexate, glucocorticoids, and anti-tumor necrosis factor therapy.

Darley MD, Saad D, Haydoura S, McGowan D, Payne JB, Cannon GW, Mikuls TR.

J Clin Rheumatol. 2015 Jan;21(1):52-3. doi: 10.1097/RHU.0000000000000202. No abstract available.

PMID:
25539440
33.

The use of natural language processing of infusion notes to identify outpatient infusions.

Nelson SD, Lu CC, Teng CC, Leng J, Cannon GW, He T, Zeng Q, Halwani A, Sauer B.

Pharmacoepidemiol Drug Saf. 2015 Jan;24(1):86-92. doi: 10.1002/pds.3720. Epub 2014 Nov 17. Erratum in: Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1225-6. Dosage error in article text. Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):477.

PMID:
25402257
34.

Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.

Gonzalez SM, Payne JB, Yu F, Thiele GM, Erickson AR, Johnson PG, Schmid MJ, Cannon GW, Kerr GS, Reimold AM, Sokolove J, Robinson WH, Mikuls TR.

J Periodontol. 2015 Feb;86(2):222-31. doi: 10.1902/jop.2014.140425. Epub 2014 Oct 9.

PMID:
25299390
35.

Disease characteristics and treatment patterns in veterans with rheumatoid arthritis and concomitant hepatitis C infection.

Patel R, Mikuls TR, Richards JS, Kerr G, Cannon GW, Baker JF.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):467-74. doi: 10.1002/acr.22463.

36.

Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis.

Cannon GW, DuVall SL, Haroldsen CL, Caplan L, Curtis JR, Michaud K, Mikuls TR, Reimold A, Collier DH, Harrison DJ, Joseph GJ, Sauer BC.

J Rheumatol. 2014 Oct;41(10):1935-43. doi: 10.3899/jrheum.140164. Epub 2014 Aug 15.

37.

Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures.

Nelson SD, Nelson RE, Cannon GW, Lawrence P, Battistone MJ, Grotzke M, Rosenblum Y, LaFleur J.

Osteoporos Int. 2014 Dec;25(12):2701-7. doi: 10.1007/s00198-014-2815-1. Epub 2014 Jul 19.

PMID:
25037601
38.

Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.

Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, Markt J, McGowan D, Kerr GS, Redman RS, Reimold A, Griffiths G, Beatty M, Gonzalez SM, Bergman DA, Hamilton BC 3rd, Erickson AR, Sokolove J, Robinson WH, Walker C, Chandad F, O'Dell JR.

Arthritis Rheumatol. 2014 May;66(5):1090-100. doi: 10.1002/art.38348.

39.

Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis.

Sokolove J, Johnson DS, Lahey LJ, Wagner CA, Cheng D, Thiele GM, Michaud K, Sayles H, Reimold AM, Caplan L, Cannon GW, Kerr G, Mikuls TR, Robinson WH.

Arthritis Rheumatol. 2014 Apr;66(4):813-21. doi: 10.1002/art.38307.

40.

Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritis.

Davis LA, Whitfield E, Cannon GW, Wolff RK, Johnson DS, Reimold AM, Kerr GS, Richards JS, Mikuls TR, Caplan L.

Rheumatology (Oxford). 2014 Jun;53(6):1014-21.

41.

Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis.

Curtis JR, Yang S, Patkar NM, Chen L, Singh JA, Cannon GW, Mikuls TR, Delzell E, Saag KG, Safford MM, DuVall S, Alexander K, Napalkov P, Winthrop KL, Burton MJ, Kamauu A, Baddley JW.

Arthritis Care Res (Hoboken). 2014 Jul;66(7):990-7. doi: 10.1002/acr.22281.

42.

The learners' perceptions survey-primary care: assessing resident perceptions of internal medicine continuity clinics and patient-centered care.

Byrne JM, Chang BK, Gilman SC, Keitz SA, Kaminetzky CP, Aron DC, Baz S, Cannon GW, Zeiss RA, Holland GJ, Kashner TM.

J Grad Med Educ. 2013 Dec;5(4):587-93. doi: 10.4300/JGME-D-12-00233.1.

43.

Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.

Davis LA, Polk B, Mann A, Wolff RK, Kerr GS, Reimold AM, Cannon GW, Mikuls TR, Caplan L.

Clin Exp Rheumatol. 2014 May-Jun;32(3):324-32. Epub 2014 Jan 20.

44.

Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experience.

Cannon GW, Wang BC, Park GS, Koenig A, Collier DH, Keystone EC.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6):919-25. Epub 2013 Nov 14.

PMID:
24237999
45.

Cost effectiveness of training rural providers to perform joint injections.

Nelson RE, Battistone MJ, Ashworth WD, Barker AM, Grotzke M, Huhtala TA, Lafleur J, Tashjian RZ, Cannon GW.

Arthritis Care Res (Hoboken). 2014 Apr;66(4):559-66. doi: 10.1002/acr.22179.

46.

Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.

Davis LA, Cannon GW, Pointer LF, Haverhals LM, Wolff RK, Mikuls TR, Reimold AM, Kerr GS, Richards JS, Johnson DS, Valuck R, Prochazka A, Caplan L.

J Rheumatol. 2013 Jun;40(6):809-17. doi: 10.3899/jrheum.121012. Epub 2013 Apr 1.

47.

Validation of Diagnostic and Procedural Codes for Identification of Acute Cardiovascular Events in US Veterans with Rheumatoid Arthritis.

Davis LA, Mann A, Cannon GW, Mikuls TR, Reimold AM, Caplan L.

EGEMS (Wash DC). 2014 Jan 14;1(3):1023. doi: 10.13063/2327-9214.1023. eCollection 2013.

48.

Retraction. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.

Schoen RE, Weissfeld JL, Sokoll LJ, Chan DW, Cannon GW, Getzenberg RH.

Cancer Res. 2013 Jan 15;73(2):1034. doi: 10.1158/0008-5472.CAN-12-3286. Epub 2012 Dec 27. No abstract available.

49.

Combined structural and synovial assessment for improved ultrasound discrimination of rheumatoid, osteoarthritic, and normal joints: a pilot study.

Kunkel GA, Cannon GW, Clegg DO.

Open Rheumatol J. 2012;6:199-206. doi: 10.2174/1874312901206010199. Epub 2012 Aug 9.

50.

Prospective study of posttraumatic stress disorder and disease activity outcomes in US veterans with rheumatoid arthritis.

Mikuls TR, Padala PR, Sayles HR, Yu F, Michaud K, Caplan L, Kerr GS, Reimold A, Cannon GW, Richards JS, Lazaro D, Thiele GM, Boscarino JA.

Arthritis Care Res (Hoboken). 2013 Feb;65(2):227-34. doi: 10.1002/acr.21778.

Supplemental Content

Loading ...
Support Center